Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Lobbying Update: $35,000 of ONCOLYTICS BIOTECH INC. lobbying was just disclosed

None

$35,000 of ONCOLYTICS BIOTECH INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Assistance with the FDA and government relationships"

You can find more data on corporate lobbying on Quiver Quantitative.

ONCY Insider Trading Activity

ONCY Insider Trades

ONCY insiders have traded $ONCY stock on the open market 14 times in the past 6 months. Of those trades, 14 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $ONCY stock by insiders over the last 6 months:

  • BERND R. SEIZINGER has made 3 purchases buying 200,000 shares for an estimated $187,224 and 0 sales.
  • JARED KELLY (Chief Executive Officer) has made 3 purchases buying 40,150 shares for an estimated $34,368 and 0 sales.
  • PATRICIA S ANDREWS purchased 35,400 shares for an estimated $30,291
  • ANDREW AROMANDO (Chief Business Officer) purchased 29,600 shares for an estimated $25,417
  • WAYNE PISANO purchased 30,000 shares for an estimated $25,338
  • DEBORAH MARGARET BROWN purchased 25,000 shares for an estimated $21,240
  • JAMES T. PARSONS purchased 10,000 shares for an estimated $10,300
  • KIRK LOOK (Chief Financial Officer) purchased 12,000 shares for an estimated $10,104
  • THOMAS CHARLES HEINEMAN (Chief Medical Officer) purchased 12,132 shares for an estimated $10,033
  • ALLISON HAGERMAN (VP, Product Development) purchased 10,000 shares for an estimated $8,298

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

ONCY Hedge Fund Activity

We have seen 27 institutional investors add shares of ONCY stock to their portfolio, and 18 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

ONCY Analyst Ratings

Wall Street analysts have issued reports on $ONCY in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • HC Wainwright & Co. issued a "Buy" rating on 11/17/2025

To track analyst ratings and price targets for ONCY, check out Quiver Quantitative's $ONCY forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles